Literature DB >> 24420546

Primary aldosteronism: a channelopathy?

Celso E Gomez-Sanchez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24420546      PMCID： PMC3977570          DOI： 10.1161/HYPERTENSIONAHA.113.02335

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.

Authors:  Ute I Scholl; Carol Nelson-Williams; Peng Yue; Roger Grekin; Robert J Wyatt; Michael J Dillon; Robert Couch; Lisa K Hammer; Frances L Harley; Anita Farhi; Wen-Hui Wang; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.

Authors:  Kenji Oki; Maria W Plonczynski; Milay Luis Lam; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-02-07       Impact factor: 4.736

Review 3.  Diagnosis and management of primary aldosteronism: an updated review.

Authors:  Chia-Ter Chao; Vin-Cent Wu; Chin-Chi Kuo; Yen-Hung Lin; Chin-Chen Chang; S Jeff Chueh; Kwan-Dun Wu; Eduardo Pimenta; Michael Stowasser
Journal:  Ann Med       Date:  2013-05-23       Impact factor: 4.709

Review 4.  Genetics of mineralocorticoid excess: an update for clinicians.

Authors:  Maria-Christina Zennaro; Amanda Jane Rickard; Sheerazed Boulkroun
Journal:  Eur J Endocrinol       Date:  2013-06-01       Impact factor: 6.664

5.  Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.

Authors:  Tracy Ann Williams; Silvia Monticone; Valentina Crudo; Richard Warth; Franco Veglio; Paolo Mulatero
Journal:  Hypertension       Date:  2012-02-13       Impact factor: 10.190

6.  Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem/progenitor cell markers.

Authors:  Sheerazed Boulkroun; Benoit Samson-Couterie; José-Felipe Golib-Dzib; Laurence Amar; Pierre-François Plouin; Mathilde Sibony; Hervé Lefebvre; Estelle Louiset; Xavier Jeunemaitre; Tchao Meatchi; Arndt Benecke; Enzo Lalli; Maria-Christina Zennaro
Journal:  Endocrinology       Date:  2011-10-04       Impact factor: 4.736

7.  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.

Authors:  Murim Choi; Ute I Scholl; Peng Yue; Peyman Björklund; Bixiao Zhao; Carol Nelson-Williams; Weizhen Ji; Yoonsang Cho; Aniruddh Patel; Clara J Men; Elias Lolis; Max V Wisgerhof; David S Geller; Shrikant Mane; Per Hellman; Gunnar Westin; Göran Åkerström; Wenhui Wang; Tobias Carling; Richard P Lifton
Journal:  Science       Date:  2011-02-11       Impact factor: 47.728

8.  The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line.

Authors:  Kenji Oki; Maria W Plonczynski; Milay Luis Lam; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Endocrinology       Date:  2012-07-13       Impact factor: 4.736

9.  Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.

Authors:  Meena Murthy; Shengxin Xu; Gianmichele Massimo; Martin Wolley; Richard D Gordon; Michael Stowasser; Kevin M O'Shaughnessy
Journal:  Hypertension       Date:  2014-01-13       Impact factor: 10.190

10.  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.

Authors:  Elena A B Azizan; Hanne Poulsen; Petronel Tuluc; Junhua Zhou; Michael V Clausen; Andreas Lieb; Carmela Maniero; Sumedha Garg; Elena G Bochukova; Wanfeng Zhao; Lalarukh Haris Shaikh; Cheryl A Brighton; Ada E D Teo; Anthony P Davenport; Tanja Dekkers; Bas Tops; Benno Küsters; Jiri Ceral; Giles S H Yeo; Sudeshna Guha Neogi; Ian McFarlane; Nitzan Rosenfeld; Francesco Marass; James Hadfield; Wojciech Margas; Kanchan Chaggar; Miroslav Solar; Jaap Deinum; Annette C Dolphin; I Sadaf Farooqi; Joerg Striessnig; Poul Nissen; Morris J Brown
Journal:  Nat Genet       Date:  2013-08-04       Impact factor: 38.330
  10 in total
  1 in total

Review 1.  Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

Authors:  Elise P Gomez-Sanchez
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.